From the Innovator’s Workbench: Jason Field, President and CEO, Shares How W. L. Gore & Associates Combines Innovation With Culture to Achieve Success

From rugged outwear to groundbreaking medical devices, W. L. Gore & Associates, a diversified material science company, serves virtually every industry you can think of.

That creativity of application can only be built by one thing – a focus on innovation.

Spotlight: James Wall, MD

A surgeon, an educator and a physician entrepreneur, James Wall, MD, has already accomplished more than most in his budding career. Recently named co-director of Stanford Biodesign’s Innovation Fellowship, he is an assistant professor of surgery at Stanford University where he focuses on minimally invasive approaches to children’s surgery. He has developed multiple medical devices,

Q&A with Thomas J. Fogarty, MD, FII Founder and Director

Given his impressive track record for inventions and the boundless energy he exhibits at the age of 85, no one would be surprised if Dr. Fogarty announced he had created his very own fountain of youth.

This passionate innovator never ceases to inspire and motivate us with the critical role he continues to play at the Fogarty Institute – checking in with the entrepreneurs on a daily basis as he brainstorms ideas and encourages them to keep looking for better pathways to solve critical problems,

Enspectra Receives Series A Funding; Moves Forward in Widening Market for Skin Cancer Detection Breakthrough

Enspectra Health, a Fogarty Institute company that is leading a digital transformation in skin cancer pathology, recently closed a $7.5 million Series A round led by Tsingyuan Ventures, a technology-focused venture fund based in Los Altos, Calif.

Funding success will serve several needs

“Fundraising has been one of our major focuses as we seek to take the startup to the next level,” said Gabriel Sanchez,

Building a Successful Roadmap to Commercialization – Recent Fogarty Institute Workshop Offers Insight on Taking Devices to Market

One of the most strategically important topics for a startup is commercialization – the point when a company transitions from research focus to generating revenue, scaling the organization, and potentially driving toward an exit. As part of its educational series, the Fogarty Institute recently hosted an impressive panel who offered their thoughts on managing this important phase of a company’s lifecycle.

Fogarty Institute Startups Make Strides; Raise Funds

It’s often said that the only constant is change. Here at the Fogarty Institute, we embrace that sentiment because in the world of medtech, change is inevitable to continue to enhance patient care. That’s why we are delighted with recent advances in funding – while the funding environment can be challenging, the industry has demonstrated resilience and agility as startups seek to get innovative devices to market.

START TYPING AND PRESS ENTER TO SEARCH